Apnimed, Inc.

APMD Nasdaq SEC CIK 1745648
Follow Apnimed Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Revenue, last quarter $12.1M −29.4% vs same quarter last year
Net income $125.9M +281.3% vs same quarter last year
EPS, diluted -
Operating income −$11.7M −97.2% vs same quarter last year
Revenue by quarter
$17.1M
$12.1M
Q2 25 Q2 26

Source: SEC XBRL filings · latest filing

News

No stories filed under Apnimed yet - coverage appears here as the news feed clusters it.